*HB1203.1*
January 25, 2024
HOUSE BILL No. 1203
_____
DIGEST OF HB 1203 (Updated January 24, 2024 1:18 pm - DI 106)
Citations Affected: IC 35-48.
Synopsis: Possession of xylazine. Makes possession of xylazine a
Class A misdemeanor, and increases the penalty to a Level 6 felony if
the person has a prior unrelated conviction for possession of xylazine.
Exempts certain persons using, distributing, or manufacturing xylazine
for veterinary purposes.
Effective: July 1, 2024.
Meltzer, Garcia Wilburn, Baird
January 9, 2024, read first time and referred to Committee on Courts and Criminal Code.
January 25, 2024, amended, reported — Do Pass.
HB 1203—LS 6290/DI 106 January 25, 2024
Second Regular Session of the 123rd General Assembly (2024)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2023 Regular Session of the General Assembly.
HOUSE BILL No. 1203
A BILL FOR AN ACT to amend the Indiana Code concerning
criminal law and procedure.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 35-48-4-18 IS ADDED TO THE INDIANA CODE
2 AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY
3 1, 2024]: Sec. 18. (a) A person who knowingly or intentionally
4 possesses xylazine commits possession of xylazine, a Class A
5 misdemeanor. However, the offense is a Level 6 felony if the person
6 has a prior unrelated conviction under this section.
7 (b) This section does not apply to one (1) or more of the
8 following:
9 (1) A person who dispenses, prescribes, or administers a drug
10 containing xylazine to a nonhuman species, if:
11 (A) the drug has been approved by the Secretary of Health
12 and Human Services under section 512 of the federal Food,
13 Drug, and Cosmetic Act (21 U.S.C. Sec. 360b); or
14 (B) the dispensing, prescription, or administration of the
15 drug is permissible under section 512(a)(4) of the federal
16 Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 360b(a)(4)).
17 (2) A person who:
HB 1203—LS 6290/DI 106 2
1 (1) manufactures, distributes, or uses xylazine as an active
2 pharmaceutical ingredient for manufacturing an animal
3 drug approved under section 512 of the federal Food,
4 Drug, and Cosmetic Act (21 U.S.C. Sec. 360b); or
5 (2) has been issued an investigation use exemption for
6 xylazine under section 512(j) of the federal Food, Drug,
7 and Cosmetic Act (21 U.S.C. Sec. 3606(j)).
8 (3) A person who manufactures, distributes, or uses a xylazine
9 bulk chemical for pharmaceutical compounding by a licensed
10 pharmacist or veterinarian.
11 (4) A person who uses xylazine for another purpose approved
12 or permitted under the federal Food, Drug, and Cosmetic Act.
13 (5) A person who:
14 (A) possesses xylazine for the purpose of engaging in an
15 activity permitted under this section; or
16 (B) delivers or transports xylazine from a person described
17 in subdivisions (1) through (5)(A) to another person
18 described in subdivisions (1) through (5)(A).
HB 1203—LS 6290/DI 106 3
COMMITTEE REPORT
Mr. Speaker: Your Committee on Courts and Criminal Code, to
which was referred House Bill 1203, has had the same under
consideration and begs leave to report the same back to the House with
the recommendation that said bill be amended as follows:
Delete everything after the enacting clause and insert the following:
(SEE TEXT OF BILL)
and when so amended that said bill do pass.
(Reference is to HB 1203 as introduced.)
MCNAMARA
Committee Vote: yeas 11, nays 1.
HB 1203—LS 6290/DI 106